Effect of cilostazol on optimized standard antiplatelet therapy in a patient with a cytochrome P450 2C19 *2/*2 genotype

ISSN： 1868-4300

Source： Cardiovascular Intervention and Therapeutics, Vol.26, Iss.1, 2011-01, pp. : 79-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 2C is an EDHF Synthase in Coronary Arteries

By Fleming I.

Trends in Cardiovascular Medicine, Vol. 10, Iss. 4, 2000-05 ,pp. : 166-170

Elsevier

Access to resources Recommend Favorite

Cytochrome P450 2D6 as a Model Antigen

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-01 ,pp. : 512-520

Bentham Science Publishers

Access to resources Recommend Favorite

Defining predictive values using three different platelet function tests for CYP2C19 phenotype status on maintenance dual antiplatelet therapy after PCI

By Zhang Hong-Zhe Kim Moo Hyun Han Jin-Yeong Jeong Young-Hoon

Platelets, Vol. 25, Iss. 4, 2014-06 ,pp. : 285-291

Informa Healthcare

Access to resources Recommend Favorite

Effect of Interferon-α Induction Therapy on Genotype 2b/3a and Low Viral Load Hepatitis C Virus Infection: A Randomized Multicentre Study

By Bjøro K. Bell H. Myrvang B. Skaug K. Raknerud N. Sandvei P. Størseth S. Ritland S. Lund-Tønnesen S. Bucher A. Hellum K. B.

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 3, 2002-03 ,pp. : 344-349

Informa Healthcare

Access to resources Recommend Favorite